EGFR Exon20 Insertion Mutations
2 clinical trials · Condition
◉ Watch EGFR Exon20 Insertion Mutations
| Record | Firm | Date |
|---|---|---|
| Real-World Effectiveness of Osimertinib for Patients With Non-Small Cell Lung Cancer (NCT05513664) | Shanghai JMT-Bio Inc. | 2022-09-01 |
| Efficacy and Safety of JMT101 Combined With Osimertinib in Patients With Non-Small Cell Lung Cancer (NCT05132777) | Shanghai JMT-Bio Inc. | 2021-11-20 |
Track EGFR Exon20 Insertion Mutations automatically
Every clearance here is in the API, with alerts when new ones post.